Ακαδημαϊκά προσόντα
Εταίρος του Βασιλικού Κολλεγίου Οφθαλμιάτρων Αγγλίας απο το 2010 και Μέλος απο το 2005
Πρώτο Εθνικό Βραβείο Οφθαλμολογίας (Duke Elder Prize) του Βασιλικού Κολλεγίου Οφθαλμιάτρων Αγγλίας
Πτυχείο Ιατρικής με Διάκριση και 10 Βραβεία (Royal London Hospital, Πανεπιστήμιο του Λονδίνου)
Πτυχείο Βιολογίας του Καρκίνου με Αριστα και πρώτο βραβείο του τμήματος χειρουργικής (UCL, Πανεπιστήμιο του Λονδίνου)
Εκπαίδευση - Κλινική Εμπειρία
2010: Διευθυντής στο Τμήμα Χειρουργικού Αμφιβληστροειδή του Πανεπιστημιακού
Οφθαλμολογικού Νοσοκομείου του Bristol, Αγγλίας
2009 - 2010: Εξειδίκευση στην Υαλοειδοαμφιβληστροειδική Χειρουργική (Πανεπιστημιακό Οφθαλμολογικό
Νοσοκομείο του Bristol, Αγγλίας)
2006-2009: Επιμελητης Οφθαλμολογίας (Πανεπιστημιακό Οφθαλμολογικό Νοσοκομείο του Bristol,
Αγγλίας)
2003-2006: Ειδικευόμενος Οφθαλμολογίας (St Thomas' Hospital, Λονδίνο)
1996-2002: Φοιτητής Ιατρικής Σχολής (Royal London Hospital, Πανεπιστήμιο του Λονδίνου)
Κλινικές Υπηρεσίες
Αντιμετώπιση παθήσεων του αμφιβληστροειδή με φάρμακα, λεΐζερ ή χειρουργείο (πχ Αποκόλληση Αμφιβληστροειδή, Οπές Ωχράς Κηλίδας, Μεμβράνες, Διαβητική Αμφιβληστροπάθεια, Εκφύλιση της Ωχράς Κηλίδας)
Αντιμετώπιση Οφθαλμικών τραυμάτων
Αντιμετώπιση επιπλοκών μετά απο χειρουργείο του καταρράκτη
Χειρουργείο καταρράκτη για περιστατικά υψηλού κινδύνου
Χειρουργέιο καταρράκτη για συνηθισμένα περιστατικά
Eξατομικευμένη προσέγγιση για την ταυτόχρονη αντιμετώπιση του καταρράκτη - μυωπίας - αστιγματισμού - πρεσβυωπίας - υπερμετρωπίας
Γενική οφθαλμολογία
Επιστημονικός Κριτής σε διεθνή επιστημονικά περιοδικά
Ophthalmology - της Αμερικανικής Ακαδημίας Οφθαλμολογίας
Journal of Ophthalmic Epidemiology
Journal of Cataract and Refractive Surgery - του Αμερικανικού και Ευρωπαϊκού Συλλόγου Χειρουργών Καταρράκτη
Investigative Ophthalmology and Visual Science
Expert Opinion on Drug Safety
British medical Journal
Ερευνητικό Έργο
Για την βελτίωση των αποτελεσμάτων του χειρουργίου του καταρράκτη
British medical Journal
Ερευνητικό Έργο
Για την βελτίωση των αποτελεσμάτων του χειρουργίου του καταρράκτη
1. Aristodemou P, Knox Cartwright NE, Sparrow JM, Johnston RL. First eye prediction error improves second eye
refractive outcome results in 2129 patients after bilateral sequential cataract surgery. Ophthalmology. 2011;118(9):1701-9.
PubMed PMID: 21762991.
4: Aristodemou P, Knox Cartwright NE, Sparrow JM, Johnston RL. Formula choice: Hoffer Q, Holladay 1, or SRK/T and refractive outcomes in 8108 eyes after cataract surgery with biometry by partial coherence interferometry. Journal of Cataract and Refractive Surgery. 2011 Jan;37(1): 63-71. PubMed PMID: 21183100.
5: Aristodemou P, Knox Cartwright NE, Sparrow JM, Johnston RL. Intraocular lens formula constant optimization and partial coherence interferometry biometry: Refractive outcomes in 8108 eyes after cataract surgery. Journal of Cataract and Refractive Surgery. 2011 Jan;37(1):50-62. PubMedPMID: 21183099.
6: Aristodemou P, Cartwright NK, Johnston R. Lack of statistical power and refractive outcomes. Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6892-3. PubMed PMID: 21123775.
7: Aristodemou P, Knox Cartwright NE, Sparrow JM, Johnston RL. Biometry formula choice and cataract refractive outcomes. Clin Experiment Ophthalmol. 2010 Jul;38(5):536-7; author reply 537-8. PubMed PMID: 20649619.
10. Knox-Cartwright NE, Aristodemou P, Sparrow JM, Johnston RL. Optimization of IOL Power Calculation Constants: By Unit or by Surgeon? Scientific Poster at the American Academy of Ophthalmology meeting, San Francisco 2009
10. Aristodemou P, Luck J. Rescuing the Running Rhexis: The restoration of the direction of a continuous circular capsulorhexis when the rhexis “runs out”. Free paper presentation. XXIV Congress of the European Society of Cataract and Refractive Surgery, London. 12th September 2006.
Για Αμφιβληστροειδή / Ωχρά Κηλίδα
1. Aristodemou P, Stylianides AC. Retinal detachment and fluoroquinolones. JAMA. 2012; 18;308(3):234; author reply 235-6. doi: 10.1001/jama.2012.6618. PubMed PMID: 22797630
2. Aristodemou P, Cartwright NK, Sparrow JM, Johnston R. Intraocular lens calculations. Ophthalmology 2011 Jun;118(6): 1221. PubMed PMID: 216402673:
Knox Cartwright NE, Aristodemou P, Sparrow JM, Johnston RL. Adjustment
of intraocular lens power for sulcus implantation. Journal of Cataract and Refractive Surgery . 2011 Apr;37(4):798-9; author reply 799-800. PubMed PMID: 21420623.4: Aristodemou P, Knox Cartwright NE, Sparrow JM, Johnston RL. Formula choice: Hoffer Q, Holladay 1, or SRK/T and refractive outcomes in 8108 eyes after cataract surgery with biometry by partial coherence interferometry. Journal of Cataract and Refractive Surgery. 2011 Jan;37(1): 63-71. PubMed PMID: 21183100.
5: Aristodemou P, Knox Cartwright NE, Sparrow JM, Johnston RL. Intraocular lens formula constant optimization and partial coherence interferometry biometry: Refractive outcomes in 8108 eyes after cataract surgery. Journal of Cataract and Refractive Surgery. 2011 Jan;37(1):50-62. PubMedPMID: 21183099.
6: Aristodemou P, Cartwright NK, Johnston R. Lack of statistical power and refractive outcomes. Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6892-3. PubMed PMID: 21123775.
7: Aristodemou P, Knox Cartwright NE, Sparrow JM, Johnston RL. Biometry formula choice and cataract refractive outcomes. Clin Experiment Ophthalmol. 2010 Jul;38(5):536-7; author reply 537-8. PubMed PMID: 20649619.
8. Knox-Cartwright NE, Aristodemou P, Johnston RL. Optimisation of IOL power calculations constants: by9. Knox-Cartwright NE, Aristodemou P, Johnston RL. Adjusting for first eye prediction error improves refractive outcomes of second eye cataract surgery UK and Ireland Society of Cataract and Refractive Surgery, 2009
unit or by surgeon? UK and Ireland Society of Cataract and Refractive Surgery, 2009.
Winner for best Poster and the Founders Medal for Best Overall Paper
10. Knox-Cartwright NE, Aristodemou P, Sparrow JM, Johnston RL. Optimization of IOL Power Calculation Constants: By Unit or by Surgeon? Scientific Poster at the American Academy of Ophthalmology meeting, San Francisco 2009
10. Aristodemou P, Luck J. Rescuing the Running Rhexis: The restoration of the direction of a continuous circular capsulorhexis when the rhexis “runs out”. Free paper presentation. XXIV Congress of the European Society of Cataract and Refractive Surgery, London. 12th September 2006.
Για Αμφιβληστροειδή / Ωχρά Κηλίδα
1. Aristodemou P, Stylianides AC. Retinal detachment and fluoroquinolones. JAMA. 2012; 18;308(3):234; author reply 235-6. doi: 10.1001/jama.2012.6618. PubMed PMID: 22797630
2. Aristodemou P, Connell P,
Romeo G, Haynes RJ. Radial extension of retinal break to the optic nerve
associated with 4% Pilocarpine. British
and Eire Association of Vitreoretinal Surgeons meeting, Reading 2008
3. Carter JG, Aristodemou P, Cherry J, Churchill AJ. DNA profile strongly associated with exudative age-related macular degeneration. Presented at the European Association for Vision and Eye Research (EVER) Annual Congress 2008, Program No. 6354, Saturday, 4th of October [www.ever.be].
4. Aristodemou P. Comment on Central retinal artery and vein collapse pressure in giant cell arteritis vs non-arteritic anterior ischaemic optic neuropathy. Eye (Lond). 2009 May;23(5):1241; PubMed PMID: 18551138.
5. Aristodemou P, Stanford M. Therapy insight: The recognition and treatment of retinal manifestations of systemic vasculitis. Nature Clinical Practice Rheumatology. 2006 Aug;2(8):443-51. Review. PubMed PMID: 16932736.
6. Aristodemou P, Membrey L. Retinal detachments are not always preceded by flashing lights or floaters. British Medical Journal 2006; 333(7563): 360
7. Aristodemou P, Stanford MR. The assessment of acute anterior uveitis in primary care. Clinical Focus – Primary Care. 2006; 1(2): 40-2
Διάφορα:
1: MacVie O, Garrott H, Aristodemou P, Harrad R. 2-0 Prolene brow suspension for paediatric ptosis: a retrospective
3. Carter JG, Aristodemou P, Cherry J, Churchill AJ. DNA profile strongly associated with exudative age-related macular degeneration. Presented at the European Association for Vision and Eye Research (EVER) Annual Congress 2008, Program No. 6354, Saturday, 4th of October [www.ever.be].
4. Aristodemou P. Comment on Central retinal artery and vein collapse pressure in giant cell arteritis vs non-arteritic anterior ischaemic optic neuropathy. Eye (Lond). 2009 May;23(5):1241; PubMed PMID: 18551138.
5. Aristodemou P, Stanford M. Therapy insight: The recognition and treatment of retinal manifestations of systemic vasculitis. Nature Clinical Practice Rheumatology. 2006 Aug;2(8):443-51. Review. PubMed PMID: 16932736.
6. Aristodemou P, Membrey L. Retinal detachments are not always preceded by flashing lights or floaters. British Medical Journal 2006; 333(7563): 360
7. Aristodemou P, Stanford MR. The assessment of acute anterior uveitis in primary care. Clinical Focus – Primary Care. 2006; 1(2): 40-2
8: Myatt N, Aristodemou P, Neale MH, Foss AJ, Hungerford JL, Bhattacharya S, A Cree I. Abnormalities of
the transforming growth factor-beta pathway in ocular melanoma. Journal of Pathology. 2000 Dec;192(4):
511-8. PubMed PMID: 11113869.
Διάφορα:
1: MacVie O, Garrott H, Aristodemou P, Harrad R. 2-0 Prolene brow suspension for paediatric ptosis: a retrospective
case series of 37 eyes. Orbit. 2013 Feb;32(1):16-9. PubMed PMID: 23387449
2: Aristodemou P. Lacrimal gland tumor outcomes. Ophthalmology. 2010 Jan;117(1):196. PubMed PMID: 20114119.
3: Garrott H, Aristodemou P, Sinclair N, Lane C, Harrad R. Long-term efficacy of 2-0 Prolene brow suspensions for congenital ptosis. Eye (Lond). 2010 Jan;24(1):175-7. Epub 2009 Oct 9. PubMed PMID: 19816518.
4: Aristodemou P, Baer R. Reversible cicatricial ectropion precipitated by topical brimonidine eye drops. Ophthalmic Plastic Reconstructive Surgery 2008 Jan-Feb;24(1):57-8. PubMed PMID: 18209648.
5:Aristodemou P, Watt L, Baldwin C, Hugkulstone C. Diplopia associated with the cosmetic use of botulinum toxin a for facial rejuvenation. Ophthalmic Plastic Reconstructive Surgery. 2006 Mar-Apr;22(2):134-6. PubMed PMID: 16550061.
6. Garrott H, Aristodemou P, Harrad RA. Unexpected prolonged duration of effect of 2-0 prolene brow suspensions in paediatric ptosis. 2009 Congress of the Royal College of Ophthalmologists.
3: Garrott H, Aristodemou P, Sinclair N, Lane C, Harrad R. Long-term efficacy of 2-0 Prolene brow suspensions for congenital ptosis. Eye (Lond). 2010 Jan;24(1):175-7. Epub 2009 Oct 9. PubMed PMID: 19816518.
4: Aristodemou P, Baer R. Reversible cicatricial ectropion precipitated by topical brimonidine eye drops. Ophthalmic Plastic Reconstructive Surgery 2008 Jan-Feb;24(1):57-8. PubMed PMID: 18209648.
5:Aristodemou P, Watt L, Baldwin C, Hugkulstone C. Diplopia associated with the cosmetic use of botulinum toxin a for facial rejuvenation. Ophthalmic Plastic Reconstructive Surgery. 2006 Mar-Apr;22(2):134-6. PubMed PMID: 16550061.
6. Garrott H, Aristodemou P, Harrad RA. Unexpected prolonged duration of effect of 2-0 prolene brow suspensions in paediatric ptosis. 2009 Congress of the Royal College of Ophthalmologists.
